Data / Drug companies / Phoenix RX LLC
Phoenix RX LLC: 61 products in the FDA NDC directory, labeler code 85509
Phoenix RX LLC (labeler code 85509) lists 61 products in the FDA National Drug Code Directory, covering 28 finished drugs by generic name. By type: 61 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on July 30, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 85509
- Products in commercial distribution
- 61
- Packages
- 171
- Finished drugs by generic name
- 28
- Prescription products
- 61
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- August 17, 1981
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 57 | 93.4% |
| Authorized generics (NDA) | 3 | 4.9% |
| Other unapproved drugs | 1 | 1.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 61 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Diclofenac sodium | 6 | 109 |
| Lidocaine | 6 | 216 |
| Cyclobenzaprine hydrochloride | 4 | 61 |
| Meloxicam | 4 | 54 |
| Ibuprofen and famotidine | 3 | 14 |
| Methocarbamol | 3 | 67 |
| Ondansetron hydrochloride | 3 | 48 |
| Naproxen and esomeprazole magnesium | 3 | 10 |
| Celecoxib | 2 | 63 |
| Gabapentin | 2 | 91 |
| Omeprazole and sodium bicarbonate | 2 | 11 |
| Ibuprofen | 2 | 190 |
| Omeprazole | 2 | 106 |
| Diclofenac sodium topical | 2 | 11 |
| Metaxalone | 2 | 38 |
| Pantoprazole | 2 | 25 |
| Diclofenac potassium | 2 | 42 |
| Methylprednisolone | 1 | 31 |
| Cyclobenzaprine hcl | 1 | 3 |
| Baclofen | 1 | 65 |
| Diclofenac epolamine | 1 | 11 |
| Naproxen | 1 | 58 |
| Rabeprazole sodium | 1 | 20 |
| Methocarbamol tablets | 1 | 20 |
| Lidocaine and capsaicin | 1 | 5 |
| Naproxen sodium | 1 | 100 |
| Tizanidine | 1 | 38 |
| Diclofenac | 1 | 12 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 15 | 24.6% |
| Tablet, film coated | 13 | 21.3% |
| Tablet, delayed release | 8 | 13.1% |
| Solution | 6 | 9.8% |
| Capsule | 5 | 8.2% |
| Ointment | 4 | 6.6% |
| Patch | 3 | 4.9% |
| Capsule, delayed release | 2 | 3.3% |
| Capsule, extended release | 2 | 3.3% |
| System | 1 | 1.6% |
| Tablet, coated | 1 | 1.6% |
| Gel | 1 | 1.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Omeprazole and Sodium Bicarbonate | 85509-1032 | Capsule | Generic drugs (ANDA) | July 30, 2025 |
| Methocarbamol | 85509-2910 | Tablet | Generic drugs (ANDA) | May 22, 2025 |
| Cyclobenzaprine hydrochloride | 85509-1014 | Tablet, film coated | Generic drugs (ANDA) | March 20, 2025 |
| Omeprazole | 85509-1644 | Capsule, delayed release | Generic drugs (ANDA) | March 6, 2025 |
| Diclofenac Potassium | 85509-1900 | Tablet, film coated | Generic drugs (ANDA) | November 1, 2024 |
| Diclofenac Potassium | 85509-2750 | Tablet, film coated | Generic drugs (ANDA) | October 21, 2024 |
| Ibuprofen | 85509-2396 | Tablet, film coated | Generic drugs (ANDA) | May 23, 2024 |
| Diclofenac Sodium | 85509-1537 | Solution | Generic drugs (ANDA) | February 19, 2024 |
| Naproxen and esomeprazole magnesium | 85509-1438 | Tablet, delayed release | Generic drugs (ANDA) | October 11, 2023 |
| Trubrexa | 85509-4000 | Patch | Other unapproved drugs | October 3, 2023 |
| Diclofenac Sodium | 85509-1369 | Solution | Generic drugs (ANDA) | May 31, 2023 |
| Ibuprofen and famotidine | 85509-1315 | Tablet | Generic drugs (ANDA) | March 15, 2023 |
| Diclofenac Epolamine | 85509-1405 | System | Authorized generics (NDA) | November 18, 2022 |
| Naproxen and esomeprazole magnesium | 85509-1203 | Tablet, delayed release | Generic drugs (ANDA) | October 6, 2022 |
| Naproxen and esomeprazole magnesium | 85509-1202 | Tablet, delayed release | Generic drugs (ANDA) | October 6, 2022 |
| Diclofenac Sodium | 85509-1581 | Gel | Generic drugs (ANDA) | September 15, 2022 |
| Diclofenac Sodium | 85509-2406 | Solution | Generic drugs (ANDA) | May 9, 2022 |
| Diclofenac Sodium | 85509-1406 | Solution | Generic drugs (ANDA) | May 9, 2022 |
| Gabapentin | 85509-1166 | Tablet | Generic drugs (ANDA) | October 1, 2021 |
| Ibuprofen and famotidine | 85509-1626 | Tablet, film coated | Generic drugs (ANDA) | August 4, 2021 |
| Ibuprofen and famotidine | 85509-1010 | Tablet, film coated | Generic drugs (ANDA) | August 4, 2021 |
| Diclofenac Sodium 1.5% | 85509-1038 | Solution | Generic drugs (ANDA) | June 4, 2021 |
| Methocarbamol | 85509-1910 | Tablet | Generic drugs (ANDA) | January 1, 2021 |
| Celecoxib | 85509-1158 | Capsule | Generic drugs (ANDA) | December 3, 2020 |
| Celecoxib | 85509-1237 | Capsule | Generic drugs (ANDA) | September 3, 2020 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.